Trial Profile
Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Goserelin (Primary) ; Cyclophosphamide
- Indications Breast cancer
- Focus Adverse reactions
- 02 Mar 2016 New trial record
- 24 Feb 2016 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.